spoonge
22-08-2015, 05:21 PM
Female Viagra approved by FDA: Will Sprout's little pink pill open Pandora's Box!?:
https://www.youtube.com/watch?v=pgOyzB_mQxM
WASHINGTON, DC — The first prescription pill to treat low sexual desire in women was finally approved by the U.S. Food and Drug Administration on Tuesday.
The little pink pill will be sold under the brand name Addyi and manufactured by Sprout Pharmaceuticals, a privately held company. It will only be available through certified and specially trained healthcare professionals and pharmacies due to its potentially dangerous side effects.
Addyi, whose generic name is flibanserin, is designed to help women get their groove back. The pill is designed for premenopausal women who suffer from hypoactive sexual desire disorder (HSDD).
The FDA rejected flibanserin twice in the past, but finally caved after a heavy lobbying campaign by Sprout and women's groups.
Women who took Addyi in a clinical study had an increase of about one orgasm a month, so that means a whopping 12 extra orgasms a year. Only problem is you need to take Addyi every day.
Addyi can cause low blood pressure, fainting, nausea, dizziness, sleepiness and shouldn't be taken with booze, but otherwise it's completely safe.
(Reported by: THE Taiwanese Animators)
'Female viagra' Flibanserin improves women's libido and gets FDA approval – TomoNews:
https://www.youtube.com/watch?v=riXXhfEhOeo
Washington- The Food and Drug Administration has approved a libido-enhancing pill for premenopausal women whose lack of sexual desire causes distress, Reuters reported.
Despite being dubbed the female viagra, unlike Viagra, which affects blood flow to the genitals, Flibanserin, works on the brain.
According to Sprout Pharmaceuticals, the privately held startup that designed the drug, Flibanserin focuses on the brain's prefrontal cortex and enables sexual desire to manifest by rebalancing neurotransmitters that influence it.
Specifically, flibanserin increases dopamine and norepinephrine, responsible for sexual excitement, and decreases serotonin, which is responsible for sexual satiety and inhibition. This is likely achieved by a reduction of glutamate transmission.
Women who took the drug in a clinical study have shown an increase of about 1.0 more sexually satisfying events per month, Reuters reported.
The pill needs to be taken every day and its most common side effects are dizziness, nausea and sleepiness.
Advocates claim that the increase in sexually satisfying events is meaningful, while critics say the benefit is outweighed by the drug’s risks.
Flibanserin will be sold under the brand name Addyi.
As the drug could potentially cause dangerously low blood pressure and fainting when taken with alcohol it will be sold exclusively through certified health care professionals and pharmacies.
(Reported by: TomoUSA)
https://www.youtube.com/watch?v=pgOyzB_mQxM
WASHINGTON, DC — The first prescription pill to treat low sexual desire in women was finally approved by the U.S. Food and Drug Administration on Tuesday.
The little pink pill will be sold under the brand name Addyi and manufactured by Sprout Pharmaceuticals, a privately held company. It will only be available through certified and specially trained healthcare professionals and pharmacies due to its potentially dangerous side effects.
Addyi, whose generic name is flibanserin, is designed to help women get their groove back. The pill is designed for premenopausal women who suffer from hypoactive sexual desire disorder (HSDD).
The FDA rejected flibanserin twice in the past, but finally caved after a heavy lobbying campaign by Sprout and women's groups.
Women who took Addyi in a clinical study had an increase of about one orgasm a month, so that means a whopping 12 extra orgasms a year. Only problem is you need to take Addyi every day.
Addyi can cause low blood pressure, fainting, nausea, dizziness, sleepiness and shouldn't be taken with booze, but otherwise it's completely safe.
(Reported by: THE Taiwanese Animators)
'Female viagra' Flibanserin improves women's libido and gets FDA approval – TomoNews:
https://www.youtube.com/watch?v=riXXhfEhOeo
Washington- The Food and Drug Administration has approved a libido-enhancing pill for premenopausal women whose lack of sexual desire causes distress, Reuters reported.
Despite being dubbed the female viagra, unlike Viagra, which affects blood flow to the genitals, Flibanserin, works on the brain.
According to Sprout Pharmaceuticals, the privately held startup that designed the drug, Flibanserin focuses on the brain's prefrontal cortex and enables sexual desire to manifest by rebalancing neurotransmitters that influence it.
Specifically, flibanserin increases dopamine and norepinephrine, responsible for sexual excitement, and decreases serotonin, which is responsible for sexual satiety and inhibition. This is likely achieved by a reduction of glutamate transmission.
Women who took the drug in a clinical study have shown an increase of about 1.0 more sexually satisfying events per month, Reuters reported.
The pill needs to be taken every day and its most common side effects are dizziness, nausea and sleepiness.
Advocates claim that the increase in sexually satisfying events is meaningful, while critics say the benefit is outweighed by the drug’s risks.
Flibanserin will be sold under the brand name Addyi.
As the drug could potentially cause dangerously low blood pressure and fainting when taken with alcohol it will be sold exclusively through certified health care professionals and pharmacies.
(Reported by: TomoUSA)